4.7 Review

Practice Parameter update: Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society

期刊

NEUROLOGY
卷 73, 期 2, 页码 133-141

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e3181a6b312

关键词

-

资金

  1. NINDS NIH HHS [R01 NS038455, R01 NS038455-09] Funding Source: Medline

向作者/读者索取更多资源

Objective: To reassess the evidence for management issues related to the care of women with epilepsy (WWE) during pregnancy. Methods: Systematic review of relevant articles published between January 1985 and June 2007. Results: It is highly probable that intrauterine first-trimester valproate (VPA) exposure has higher risk of major congenital malformations (MCMs) compared to carbamazepine and possible compared to phenytoin or lamotrigine. Compared to untreated WWE, it is probable that VPA as part of polytherapy and possible that VPA as monotherapy contribute to the development of MCMs. It is probable that antiepileptic drug (AED) polytherapy as compared to monotherapy regimens contributes to the development of MCMs and to reduced cognitive outcomes. For monotherapy, intrauterine exposure to VPA probably reduces cognitive outcomes. Further, monotherapy exposure to phenytoin or phenobarbital possibly reduces cognitive outcomes. Neonates of WWE taking AEDs probably have an increased risk of being small for gestational age and possibly have an increased risk of a 1-minute Apgar score of <7. Recommendations: If possible, avoidance of valproate (VPA) and antiepileptic drug (AED) polytherapy during the first trimester of pregnancy should be considered to decrease the risk of major congenital malformations (Level B). If possible, avoidance of VPA and AED polytherapy throughout pregnancy should be considered to prevent reduced cognitive outcomes (Level B). If possible, avoidance of phenytoin and phenobarbital during pregnancy may be considered to prevent reduced cognitive outcomes (Level C). Pregnancy risk stratification should reflect that the offspring of women with epilepsy taking AEDs are probably at increased risk for being small for gestational age (Level B) and possibly at increased risk of 1-minute Apgar scores of <7 (Level C). Neurology(R) 2009; 73: 133-141

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Clinical Neurology

Neurophysiological and Clinical Correlates of Acute Posthypoxic Myoclonus

Brin E. Freund, Peter W. Kaplan

Summary: Prognosis after cardiorespiratory arrest depends on neurological examination supported by neuroimaging and neurophysiological testing. Acute posthypoxic myoclonus (PHM) is clinically significant and historically associated with poor outcome, but can have different forms with varying prognoses. Neurophysiological tests, especially electroencephalogram, and clinical phenotyping are crucial in distinguishing malignant and benign forms of acute PHM. This review discusses the neurophysiological and phenotypic markers of different forms of acute PHM, a clinical approach for evaluating prognosis following cardiorespiratory arrest, and areas that need further study.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2023)

Article Clinical Neurology

A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® alprazolam for rapid seizure termination

Jacqueline French, Victor Biton, Hina Dave, Kamil Detyniecki, Michael A. Gelfand, Hui Gong, Kore Liow, Terence J. O'Brien, Ahmed Sadek, Bree DiVentura, Brittany Reich, Jouko Isojarvi

Summary: This study demonstrated that Staccato alprazolam administered via a breath-actuated device can rapidly terminate epileptic seizures in hospitalized patients. The next step is to conduct a Phase 3 confirmatory study to further evaluate the efficacy and safety of Staccato alprazolam for seizure termination in an outpatient setting.

EPILEPSIA (2023)

Review Clinical Neurology

Nonconvulsive status epilepticus following cardiac arrest: overlooked, untreated and misjudged

Pia De Stefano, Peter W. Kaplan, Herve Quintard, Margitta Seeck, Raoul Sutter

Summary: Seizures and status epilepticus (SE) are common in comatose cardiac arrest survivors, but little is known about nonconvulsive SE (NCSE). This study aimed to compile evidence from the literature on the frequency and outcome of NCSE in adult patients remaining in coma after resuscitation. The results showed that NCSE occurred in a small percentage of patients, and the favorable outcome after NCSE was observed in approximately one-fourth of the patients. However, the limited quality of data calls for further investigation on the effects of NCSE on outcome.

JOURNAL OF NEUROLOGY (2023)

Article Public, Environmental & Occupational Health

Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study

Shuang Wang, Kimford J. Meador, Jayne Pawasauskas, Adam K. Lewkowitz, Kristina E. Ward, Todd N. Brothers, Abraham Hartzema, Brian J. Quilliam, Xuerong Wen

Summary: This study aimed to assess the effects of buprenorphine and methadone treatment during early and late pregnancy on perinatal and pregnancy outcomes. The results showed that there were varying risks associated with the two treatments, with buprenorphine potentially being the preferred choice.

DRUG SAFETY (2023)

Editorial Material Clinical Neurology

Unjustified allegation on cancer risks in children of mothers with epilepsy taking high-dose folic acid during pregnancy-No proof of a causal relationship

Randi von Wrede, Juri-Alexander Witt, Stephane Auvin, Anita Devlin, Lieven Lagae, Anthony Marson, Kimford J. Meador, Terence J. O'Brien, Jun Park, Rainer Surges, Eugen Trinka, Samuel Wiebe, Christoph Helmstaedter

EPILEPSIA (2023)

Article Biochemistry & Molecular Biology

Dual functions of TET1 in germ layer lineage bifurcation distinguished by genomic context and dependence on 5-methylcytosine oxidation

Bernard K. van der Veer, Lehua Chen, Colin Custers, Paraskevi Athanasouli, Mariana Schroiff, Riet Cornelis, Jonathan Sai-Hong Chui, Richard H. Finnell, Frederic Lluis, Kian Peng Koh

Summary: Gastrulation begins when the epiblast forms the primitive streak or becomes definitive ectoderm. During this process, TET1 plays a role in both transcriptional activation and repression, but the mechanisms are not well understood. By converting mouse embryonic stem cells into neuroprogenitors, researchers found that TET1 regulates the formation of mesoderm and endoderm by suppressing Wnt/beta-catenin and Nodal signalling. TET1 also affects chromatin accessibility and gene expression through DNA demethylation in a context-dependent manner. These findings highlight the versatile functions of TET1 during development.

NUCLEIC ACIDS RESEARCH (2023)

Letter Clinical Neurology

Benefits and Risks of Periconceptional Folic Acid Supplementation

P. Emanuela Voinescu, Page B. Pennell, Kimford Meador

JAMA NEUROLOGY (2023)

Article Pharmacology & Pharmacy

Expert consensus on neurodevelopmental outcomes in pregnancy pharmacovigilance studies

R. L. Bromley, M. Bickle Graz, M. Bluett-Duncan, C. Chambers, P. Damkier, K. Dietrich, H. Dolk, K. Grant, S. Mattson, K. J. Meador, H. Nordeng, T. F. Oberlander, A. Ornoy, A. Revet, J. Richardson, J. Rovet, L. Schuler-Faccini, E. Smearman, V. Simms, C. Vorhees, K. Wide, A. Wood, L. Yates, E. Ystrom, T. A. Supraja, J. Adams

Summary: The study aims to achieve consensus on the core neurodevelopmental outcomes, optimize methodologies, and overcome barriers in conducting pregnancy pharmacovigilance studies with neurodevelopmental outcomes. The vision is to establish a comprehensive understanding of neurodevelopmental outcomes in pregnancy pharmacovigilance through a complementary set of studies.

FRONTIERS IN PHARMACOLOGY (2023)

Article Clinical Neurology

Catamenial epilepsy occurrence and patterns in a mixed population of women with epilepsy

P. Emanuela Voinescu, McKenna Kelly, Jacqueline A. French, Cynthia Harden, Anne Davis, Connie Lau, Alexa Ehlert, Stephanie Allien, Emma Osterhaus, Sarah Barnard, Rishabh Jain, Page B. Pennell

Summary: This study examined the occurrence and distribution of catamenial epilepsy patterns in women with epilepsy not receiving hormonal therapies. The results showed that out of 89 women enrolled, 23 were eligible for analysis, with 12 meeting criteria for catamenial epilepsy. App-based tracking proved to be a useful tool in determining catamenial patterns.

EPILEPSIA (2023)

Article Clinical Neurology

Utilization of Antiseizure Medications in Women of Childbearing Age With Epilepsy and Nonepilepsy Indications

Oluwadolapo D. Lawal, Kimford J. Meador, Anne L. Hume, Xuerong Wen

Summary: The study analyzed the pattern of antiseizure medication use in women of childbearing age with different indications, showing an increasing trend in the use of newer-generation ASMs and a decreasing trend in the use of older ASMs. The risk of teratogenicity associated with newer medications is largely unknown, emphasizing the importance of counseling and education in prescribing ASMs for women of childbearing age.

NEUROLOGY (2023)

Meeting Abstract Neurosciences

Expert consensus on neurodevelopmental outcomes in pregnancy pharmacovigilance studies

Rebecca Bromley, Miriam Bickle Graz, Matthew Bluett-Duncan, Christina Chambers, Per Damkier, Kim Dietrich, Helen Dolk, Kimberley Grant, Sarah Mattson, Kim Meador, Hedvig Nordeng, Tim Oberlander, Asher Ornoy, Alexis Revet, Jonathan Richardson, Joanne Rovet, Lavinia Schuler-Faccini, Erica Smearman, Victoria Simms, Charles Vorhees, Katrina Wide, Amanda Wood, Laura Yates, Evinid Ystrom, T. A. Supraja, Jane Adams

NEUROTOXICOLOGY AND TERATOLOGY (2023)

Article Clinical Neurology

Highlights From the Annual Meeting of the American Epilepsy Society 2022

Ignacio Valencia, Allyson L. Alexander, Danielle M. Andrade, Miguel Arevalo-Astrada, Clio Rubinos, Nancy Auer, Jacquelyn L. Bainbridge, Sallie A. Baxendale, Fabrice Bartolomei, Danielle A. Becker, Anne T. Berg, Andrea Bernasconi, Neda Bernasconi, Boris Bernhardt, Shivani Bhatnagar, Ingmar Bluemcke, Hal Blumenfeld, Gordon F. Buchanan, David E. Burdette, Jorge G. Burneo, Robyn M. Busch, Patrick Chauvel, Jeannie Chin, Lisa Clifford, Kelly R. Conner, Mark J. Cook, Jeannine Conway, Ramon Diaz-Arastia, Cornelia Drees, Jacqueline A. French, Taneeta Mindy Ganguly, Michael A. Gelfand, Tracy A. Glauser, Ezequiel Gleichgerrcht, Alica M. Goldman, Jorge Gonzalez-Martinez, Jean Gotman, Zachary Grinspan, Shanna Guilfoyle, Gita Gupta, Michael Hammer, Adam L. Hartman, Katie Hentges, R. Edward Hogan, Linda Huh, Ann Hyslop, Barbara Jobst, Colin B. Josephson, Sarah A. Kelley, Kelly Knupp, Matthias Koepp, Sanjeev Kothare, Esther Krook-Magnuson, Jasmine Kwasa, Maite La Vega-Talbott, Alice D. Lam, Jong Woo Lee, Daniel H. Lowenstein, Sarita Maturu, Luis Carlos Mayor, Carrie McDonald, Heather R. McKee, Guy M. McKhann, Kimford J. Meador, Heather C. Mefford, Elizabeth H. Michael, Mohamad A. Mikati, John J. Millichap, James W. Mitchell, Leah S. Myers, Dean Naritoku, Kerri L. Neville, Jeffrey Noebels, Terence J. O'Brien, Chima O. Oluigbo, Anup D. Patel, Milena K. Pavlova, Jeanne T. Paz, Page B. Pennell, M. Scott Perry, Piero Perucca, Asla Pitkaenen, Madona Plueger, Mary Jo Pugh, Mark Quigg, Shilpa B. Reddy, Christopher Ryan, Tamara S. Reynolds, Martha Sajatovic, Cesar Santana-Gomez, Linsday Schommer, Stephan Schuele, Renee A. Shellhaas, Daniel W. Shrey, Rani K. Singh, Michael R. Sperling, Saher Suleman, Jessica W. Templer, Maria Thom, Eugen Trinka, Sophia M. Varadkar, Naymee Velez-Ruiz, Jana Veliskova, Yuliya Voskobiynyk, Janelle L. Wagner, Jacy L. Wagnon, Claire Waller, Jill Waller, Zhong Irene Wang, Michelle W. Welborn, Elaine Wirrell, Barbara Jobst

Summary: The American Epilepsy Society Meeting 2022 in Nashville attracted over 6000 attendees and felt as busy as before the pandemic. The meeting provided a variety of symposia covering topics such as seizure generation, epilepsy pathophysiology, anti-seizure medications, and new treatment tools. It also included discussions on epilepsy comorbidities, practical issues in epilepsy care, and personal stories from patient advocates. Special lectures and smaller group sessions focused on specific areas of interest, and satellite symposia showcased the latest advancements in pharmaceutical and engineering fields.

EPILEPSY CURRENTS (2023)

Article Clinical Neurology

Cognitive outcomes at age 3 years in children with fetal exposure to antiseizure medications (MONEAD study) in the USA: a prospective, observational cohort study

Kimford J. Meador, Morris J. Cohen, David W. Loring, Abigail G. Matthews, Carrie Brown, Chelsea P. Robalino, Angela K. Birnbaum, Paula E. Voinescu, Laura A. Kalayjian, Elizabeth E. Gerard, Evan R. Gedzelman, Julie Hanna, Jennifer Cavitt, Maria Sam, Jacqueline A. French, Sean Hwang, Alison M. Pack, Page B. Pennell, MONEAD Invest Grp

Summary: This study aimed to investigate the neurodevelopmental effects of fetal exposure to commonly used antiseizure medications, and found no difference in neurodevelopmental outcomes between children with fetal exposure to newer antiseizure medications compared with unexposed children.

LANCET NEUROLOGY (2023)

Review Clinical Neurology

From Alpha to Zeta: A Systematic Review of Zeta Waves

Brin E. Freund, Tara Brigham, Saif Salman, Peter W. Kaplan, William O. Tatum

Summary: Electroencephalogram (EEG) is essential for prognostication and diagnosis in critically ill patients. It can differentiate neurological disorders and indicate a potential for seizures. This study aimed to characterize zeta waves and found that they are often associated with focal cerebral lesions and a heightened risk for seizures.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2023)

Article Clinical Neurology

Prediction tools and risk stratification in epilepsy surgery

Levente Hadady, Michael R. Sperling, Juan Luis Alcala-Zermeno, Jacqueline A. French, Patricia Dugan, Lara Jehi, Daniel Fabo, Peter Klivenyi, Guido Rubboli, Sandor Beniczky

Summary: This study conducted external validation of previously published epilepsy surgery prediction tools using a large independent multicenter dataset and found that these tools can effectively stratify patients for surgery and freedom from disabling seizures.

EPILEPSIA (2023)

暂无数据